Magid Abraham, PhD

Founder and CEO of Neurawell Therapeutics
Boca Raton, FL

Dr. Magid Abraham is founder and CEO of Neurawell Therapeutics, a pharmaceutical company developing mental health treatments. He is also Chairman of Crimson Capital, a private investment company. Magid was founding CEO of comScore for 14 years, which he took public in 2007, focusing on innovation and industry leadership. He was founder and CEO of Paragren Technologies, producing CRM systems. Magid was president of IRI, a major international research company, which he led through sustained growth and innovation. He became a Visiting Scholar at Stanford in 2016, where he taught for three years at the Graduate School of Business. Magid serves on a number of commercial and institutional boards.

Magid is a world expert on consumer and market measurement and analytics He has authored seminal award winning articles. Magid received the Advertising Research Foundation’s “Lifetime Achievement Award.” He earned the AMA’s Parlin award and MIT’s Buck Weaver Award, both in recognition for lifetime contributions and leadership in the theory and practice of Marketing Science. He was named EY Entrepreneur of the Year and inducted in the Entrepreneurship Hall of Fame and designated “Technology Pioneer” by the World Economic Forum. Magid received a PhD and an MBA from MIT, after earning his Ingenieur de L’École Polytechnique degree in France.

DCI Fellow: Linda Abraham